SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Persson Mattias)
 

Sökning: WFRF:(Persson Mattias) > High prevalence of ...

  • Ahmad, IrmaDepartment of Infectious Diseases, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Department of Radiation Oncology, Stanford University, Stanford, CA, United States,Örebro Univ, Fac Med & Hlth, Dept Infect Dis, Örebro, Sweden. (författare)

High prevalence of persistent symptoms and reduced health-related quality of life 6 months after COVID-19

  • Artikel/kapitelEngelska2023

Förlag, utgivningsår, omfång ...

  • 2023-02-02
  • Frontiers Media S.A.2023
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-104509
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-104509URI
  • https://doi.org/10.3389/fpubh.2023.1104267DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-205360URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-498893URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • BACKGROUND: The long-term sequelae after COVID-19 constitute a challenge to public health and increased knowledge is needed. We investigated the prevalence of self-reported persistent symptoms and reduced health-related quality of life (HRQoL) in relation to functional exercise capacity, 6 months after infection, and explored risk factors for COVID-19 sequalae.METHODS: This was a prospective, multicenter, cohort study including 434 patients. At 6 months, physical exercise capacity was assessed by a 1-minute sit-to-stand test (1MSTST) and persistent symptoms were reported and HRQoL was evaluated through the EuroQol 5-level 5-dimension (EQ-5D-5L) questionnaire. Patients with both persistent symptoms and reduced HRQoL were classified into a new definition of post-acute COVID syndrome, PACS+. Risk factors for developing persistent symptoms, reduced HRQoL and PACS+ were identified by multivariable Poisson regression.RESULTS: Persistent symptoms were experienced by 79% of hospitalized, and 59% of non-hospitalized patients at 6 months. Hospitalized patients had a higher prevalence of self-assessed reduced overall health (28 vs. 12%) and PACS+ (31 vs. 11%). PACS+ was associated with reduced exercise capacity but not with abnormal pulse/desaturation during 1MSTST. Hospitalization was the most important independent risk factor for developing persistent symptoms, reduced overall health and PACS+.CONCLUSION: Persistent symptoms and reduced HRQoL are common among COVID-19 survivors, but abnormal pulse and peripheral saturation during exercise could not distinguish patients with PACS+. Patients with severe infection requiring hospitalization were more likely to develop PACS+, hence these patients should be prioritized for clinical follow-up after COVID-19.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Edin, Alicia,1985-Umeå universitet,Institutionen för kirurgisk och perioperativ vetenskap,Umeå Univ, Dept Surg & Perioperat Sci, Umeå, Sweden.(Swepub:umu)alalid03 (författare)
  • Granvik, ChristofferUmeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)chgr0038 (författare)
  • Kumm Persson, LowaUmeå universitet,Institutionen för kirurgisk och perioperativ vetenskap,Umeå Univ, Dept Surg & Perioperat Sci, Umeå, Sweden. (författare)
  • Tevell, Staffan,1975-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Infectious Diseases, Karlstad Hospital, Karlstad, Sweden; Centre for Clinical Research and Education, Region Värmland, Karlstad, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Karlstad Hosp, Dept Infect Dis, Karlstad, Sweden.;Ctr Clin Res & Educ, Karlstad, Sweden.;Örebro Univ, Fac Med & Hlth, Sch Med Sci, Örebro, Sweden.(Swepub:oru)stl (författare)
  • Månsson, EmeliUppsala universitet,Centrum för klinisk forskning, Västerås (författare)
  • Magnuson, AndersCenter for Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden,Örebro Univ, Fac Med & Hlth, Ctr Clin Epidemiol & Biostat, Sch Med Sci, Örebro, Sweden. (författare)
  • Marklund, IngelaUmeå universitet,Institutionen för samhällsmedicin och rehabilitering,Centre for Clinical Research and Education, Region Värmland, Karlstad, Sweden,Ctr Clin Res & Educ, Karlstad, Sweden.;Umeå Univ, Dept Community Med & Rehabil, Umeå, Sweden.(Swepub:umu)inamad99 (författare)
  • Persson, Ida-LisaUmeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)idpe0053 (författare)
  • Kauppi, AnnaUmeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)anakai97 (författare)
  • Ahlm, Clas,1956-Umeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)clah0001 (författare)
  • Forsell, Mattias N. E.Umeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)mafo0173 (författare)
  • Sundh, Josefin,1972-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Respiratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Örebro Univ, Fac Med & Hlth, Dept Resp Med, Örebro, Sweden.(Swepub:oru)jnsh (författare)
  • Lange, Anna,1975-Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Infectious Diseases,Department of Radiation Oncology, Stanford University, Stanford, CA, United States,Örebro Univ, Fac Med & Hlth, Dept Infect Dis, Örebro, Sweden.(Swepub:oru)aalg (författare)
  • Cajander, Sara,1980-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Infectious Diseases, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Department of Radiation Oncology, Stanford University, Stanford, CA, United States,Örebro Univ, Fac Med & Hlth, Dept Infect Dis, Örebro, Sweden.(Swepub:oru)scr (författare)
  • Normark, JohanUmeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)jono0053 (författare)
  • Department of Infectious Diseases, Faculty of Medicine and Health, Örebro University, Örebro, SwedenDepartment of Radiation Oncology, Stanford University, Stanford, CA, United States (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Frontiers In Public Health: Frontiers Media S.A.112296-2565

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy